In addition, 3-CQA has shown promise in countering high-fat diet (HFD)-induced activation of the TLR4 signaling pathway and the expression of TNF-α and IL-6 in the liver, thus ameliorating non-alcoholic fatty liver disease (NAFLD) (13). Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.